Haas LF (2002)
Luis Morquio (1867-1935). J Neurol Neurosurg Psychiatry 72:787.
Holzgreve W, Grobe H, von Figura K, Kresse H, Beck H, Mattei JF (1981)
Morquio syndrome: clinical findings in 11 patients with MPS IVA and 2 patients
with MPS IVB. Hum Genet 57:360-365.
Hoogerbrugge PM, Brouwer OF, Bordigoni P, Ringden O, Kapaun P, Ortega JJ,
O'Meara A, Cornu G, Souillet G, Frappaz D, et al. (1995)
Allogeneic bone marrow transplantation for lysosomal storage diseases. The
European Group for Bone Marrow Transplantation [see comments]. Lancet 345:1398-1402.
Kakkis ED, McEntee MF, Schmidtchen A, Neufeld EF, Ward DA, Gompf RE, Kania
S, Bedolla C, Chien SL, Shull RM (1996)
Long-term and highdose trials of enzyme replacement therapy in the canine
model of mucopolysaccharidosis I. Biochem Mol Med 58:156-167
Kakkis ED, Muenzer J, Tiller GE, Waber L, John Belmont J, Merry Passage
M, Izykowski B, Phillips J, Doroshow R, Irv Walot I, Richard Hoft R, Yu
KT, Okazaki S, Dave Lewis D, Ralph Lachman R, Jerry N. Thompson JN, Neufeld
FE (2001)
Enzyme-Replacement Therapy in Mucopolysaccharidosis I. N Engl J Med 344:182-188.
Kakkis ED (2002)
Enzyme replacement therapy for the mucopolysaccharide storage disorders.
Expert Opin Investig Drugs 11:675-685.
Keeling KM, Bedwell DM (2002)
Clinically relevant aminoglycosides can suppress disease-associated premature
stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
J Mol Med 80:367-376.
Kettles DI, Sheppard M, Liebmann RD, Davidson C (2002)
Left ventricular aneurysm, aortic valve disease and coronary narrowing in
a patient with Hunter's syndrome. Cardiovasc Pathol 11:94-96.
Keulemans JL, Sinigerska I, Garritsen VH, Huijmans JG, Voznyi YV, Van Diggelen
OP, Kleijer WJ (2002)
Prenatal diagnosis of the Hunter syndrome and the introduction of a new
fluorimetric enzyme assay. Prenat Diagn 22:1016-1021.
Khan FA, Khan FH (2002)
Use of the laryngeal mask airway in mucopolysaccharidoses. Paediatr Anaesth
12:468.
Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W (2002)
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic
leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant
30:215-222.